CICALESE, MARIA PIA
 Distribuzione geografica
Continente #
NA - Nord America 3.215
EU - Europa 3.149
AS - Asia 2.727
SA - Sud America 588
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 81
OC - Oceania 13
Totale 9.993
Nazione #
US - Stati Uniti d'America 3.028
RU - Federazione Russa 1.535
SG - Singapore 976
CN - Cina 848
IT - Italia 677
BR - Brasile 469
SE - Svezia 293
HK - Hong Kong 271
VN - Vietnam 240
DE - Germania 139
GB - Regno Unito 122
FR - Francia 117
BD - Bangladesh 105
CA - Canada 100
IN - India 85
AT - Austria 44
AR - Argentina 41
ES - Italia 38
PL - Polonia 36
JP - Giappone 35
MX - Messico 34
NL - Olanda 34
FI - Finlandia 32
ZA - Sudafrica 28
TR - Turchia 26
IQ - Iraq 25
EC - Ecuador 22
CO - Colombia 19
ID - Indonesia 18
MY - Malesia 16
LT - Lituania 14
UA - Ucraina 14
IE - Irlanda 13
CR - Costa Rica 11
DZ - Algeria 11
JM - Giamaica 11
AU - Australia 10
PE - Perù 9
UY - Uruguay 9
BE - Belgio 8
IL - Israele 8
IR - Iran 8
UZ - Uzbekistan 8
KE - Kenya 7
KR - Corea 7
PK - Pakistan 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
ET - Etiopia 6
MA - Marocco 6
RO - Romania 6
TT - Trinidad e Tobago 6
BG - Bulgaria 5
EG - Egitto 5
GT - Guatemala 5
NI - Nicaragua 5
PY - Paraguay 5
TN - Tunisia 5
CL - Cile 4
CZ - Repubblica Ceca 4
EU - Europa 4
NG - Nigeria 4
NP - Nepal 4
PR - Porto Rico 4
CI - Costa d'Avorio 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
CU - Cuba 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
KW - Kuwait 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
NA - Namibia 1
Totale 9.770
Città #
Singapore 513
Ashburn 401
Moscow 313
San Jose 313
Hong Kong 266
Dallas 262
Shanghai 185
New York 177
Milan 161
Council Bluffs 123
Beijing 116
Hefei 101
Ho Chi Minh City 84
Lauterbourg 84
Los Angeles 81
Princeton 79
Lawrence 78
Santa Clara 67
Phoenix 66
Rome 64
São Paulo 53
Hanoi 50
Nuremberg 36
Orem 36
Boardman 35
Munich 35
Denver 31
Warsaw 31
Tokyo 30
Brooklyn 26
Chennai 26
London 26
Atlanta 24
Chicago 24
Guangzhou 23
Toronto 23
Poplar 22
Brescia 21
Montreal 21
Stockholm 21
Helsinki 20
Houston 20
Naples 20
Turin 20
Vienna 20
Seattle 19
Cesano Boscone 18
Frankfurt am Main 18
Miano 18
Johannesburg 17
Buffalo 15
Mexico City 15
Rio de Janeiro 15
Ankara 13
Monza 13
The Dalles 13
Haiphong 12
Miami 12
Pune 12
Shenzhen 12
Amsterdam 11
Florence 11
Hangzhou 11
Madrid 11
Manchester 11
Mumbai 11
Philadelphia 11
Washington 11
Boston 10
Calgary 10
Da Nang 10
Dublin 10
Curitiba 9
Guayaquil 9
Lima 9
Paris 9
San José 9
Barcelona 8
Belo Horizonte 8
Brasília 8
Changsha 8
Kuala Lumpur 8
Milwaukee 8
Montevideo 8
Omaha 8
Salvador 8
Tashkent 8
Verona 8
Biên Hòa 7
Cambridge 7
Columbus 7
Falkenstein 7
Genoa 7
Modena 7
Ottawa 7
Sorocaba 7
Tianjin 7
Turku 7
Bogotá 6
Brisbane 6
Totale 4.793
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 456
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 264
Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children 208
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 185
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 169
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 166
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset 158
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 150
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 149
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 146
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 143
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 141
Efficacy and safety of an amino-acid-based formula during the period of weaning children with intestinal failure and parenteral nutrition 138
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 137
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation 135
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 134
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 134
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 124
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 124
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients 120
A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome 120
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency 119
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 119
Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients 118
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 118
Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy 117
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 117
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation 116
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 115
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 114
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 113
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 111
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 111
Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes 111
Correction to: A Case of Two Adult Brothers with Wiskott‑Aldrich Syndrome, One Treated with Gene Therapy and One with HLA‑Identical Hematopoietic Stem Cell Transplantation (Journal of Clinical Immunology, (2022), 42, 2, (421-425), 10.1007/s10875-021-01157-6) 109
Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: Report of the italian primary immunodeficiency network 109
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 100
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 98
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 98
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report 97
Circulating follicular helper and follicular regulatory T cells are severely compromised in human CD40 deficiency: A case report 97
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 96
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: Change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response 95
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 92
Beta2 integrins are required for follicular helper T cell differentiation in humans 91
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 90
Urogenital Abnormalities in Adenosine Deaminase Deficiency 90
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients (Journal of Clinical Immunology, (2021), 41, 7, (1633-1647), 10.1007/s10875-021-01098-0) 89
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients 89
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 87
Treatment with rapamycin can restore regulatory T-cell function in IPEX patients 87
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 87
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome 86
Clinical applications of gene therapy for primary immunodeficiencies 85
T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation 84
Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans 84
Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology 84
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 82
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 79
EFFICACY OF THE ANDRESEN ACTIVATOR BEFORE PEAK GROWTH IN CLASS II PATIENTS 79
New perspectives in gene therapy for inherited disorders 78
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic 77
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases 74
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 74
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit 73
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency 73
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 72
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity 71
Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children 71
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety 71
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity 69
Gene therapy in rare diseases: The benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID 68
NADPH Oxidase Deficiency: A Multisystem Approach 66
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity 66
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency 65
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy 65
Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation 65
Editorial: Follicular Helper T Cells in Immunity and Autoimmunity 63
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 62
Neutrophils drive type-I interferon production and autoantibodies in Wiskott-Aldrich syndrome 62
First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature 62
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 62
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 60
LENTIVIRAL VECTOR TRANSDUCED CD34+CELLS FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME 60
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β 60
Treatment of chronic hepatitis C in children with pegylated interferon and ribavirin : the impact of dose 60
Relationship between severe obesity and gut inflammation in children: what’s next? 59
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 57
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 57
La mucosite post-chemioterapia in bambini sottoposti a terapia genica, l'esperienza del San Raffaele di Milano 55
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 54
Requesting iodine supplementation in children on parenteral nutrition 54
Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer 54
CXCR5-CXCL13 axis markers in full-term and preterm human neonates in the first weeks of life 50
NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential 49
Management of autoimmune hepatitis in children: how many steps away from common agreement? 49
Gene therapy trial with lentiviral vector transduced CD34+cells for the treatment of Wiskott-Aldrich Syndrome 46
Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects 46
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review 34
Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series 32
Totale 9.809
Categoria #
all - tutte 53.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 13 6 3 8 9 33 4 6 3
2022/2023588 171 113 47 4 11 67 18 56 37 15 27 22
2023/2024604 47 33 59 69 47 100 29 43 5 28 25 119
2024/20251.762 161 42 66 75 76 130 214 227 282 193 120 176
2025/20265.446 347 340 431 733 460 188 437 384 1.365 314 183 264
2026/20271.423 247 351 293 532 0 0 0 0 0 0 0 0
Totale 9.993